Novosti
Khirurgii
This journal is
indexed in Scopus



Year 2009 Vol. 17 No 1

IN ASSISTANCE TO PRACTICIONER

BUSHMA K.M., SPAS V.V., SHAPEL I.A., GERASIMCHIK P.A., GRIGORUK A.V.

TO THE QUESTION OF AMINOGLYCOSIDES NEPHROTOXICITY

Aminoglycoside antibiotics play an important role in the antibacterial therapy of sepsis. Their administration is considerably limited by the risk of nephrotoxicity development (up to 25% cases). Science has several approaches concerning nephrotoxicity prevention based on the external factors management: single average daily dose administration, shortening of the therapy courses (not longer than 7 days), adequate hydratation, refusal to use other nephrotoxic agents during aminoglycoside course, kidney function control. However it has been cleared up that external factors stipulate for only 50% of nephrotoxicity. There are also internal, genetically grounded factors for aminoglycoside nephrotoxicity. They are: small diameter of proximal tubules and epithelial cells covering their lumen; high activity of lactatedehydrogenase, succinatdehydrogenase and acid phosphatase ensymopathias, small amount of ribonucleoproteins; reduced mitochondrial respiration capacity; active lipid peroxidation system; weak antioxidant potential. A low level of restored glutathione contributes considerably to nephrotoxicity realisation. At present some investigations are being carried on to develop the method of prevention of aminoglycoside nephrotoxicity influencing the internal risk factors.

Keywords: sepsis, antibiotics, aminoglycosides, nephrotoxicity.
p. 157 - 162 of the original issue
References
  1. Марино, П. Сведения об антибактериальных средствах: пер. с англ. / П. Марино // Интенсивная терапия. – М.: «ГОЭТАР МЕДИЦИНА», 1999. – С. 573-577.
  2. Страчунский, Л. С. Аминогликозиды / Л. С. Страчунский, С. Н. Козлов // Современная антимикробная химиотерапия: руководство для врачей. – М.: «Боргес», 2002. – 291 с.
  3. 3. Интенсивная терапия тяжёлого сепсиса и септического шока: осн. пол. методич. рек. Калужской согл. конф. / под ред. В. С. Савельева [и др.]; РАСХИ. – Калуга, 2004. – 20 c.
  4. Luft, F. J. Clinical significance of renal changes engendered by aminoglycosides in man / F. J. Luft // J. Antimicrob. Chemother. – 1984. – Vol. 13. – Suppl. A. – P. 23-28.
  5. Cellular mechanism of aminoglycoside tolerance in long-term gentamicin treatment / D. Sundin [et al.] // Am. J. Physiol. – 1997. – Vol. 272. – P. 1309-1318.
  6. Aminoglycoside nephrotoxicity in cirrhosis. Value of urinary beta 2-microglobulin to discriminate functional renal failure from acute tubular damage / I. Cabrera [et al.] // Gastroenterol. – 1982. – Vol. 82. – P. 97-105.
  7. Cephalothin plus an aminoglycoside is more nephrotoxic than methicillin plus an aminoglycoside / J. Wade [et al.] // Lancet. – 1978. – Vol. 2, N 8090. – P. 604-606.
  8. Nephrotoxicity due to combination antibiotic therapy with vancomycin and aminoglycosides in septic critically ill patients / P. Мalacarne [et al.] // Сhemotherapy. – 2006. – Vol. 52, N. 4. – Р. 178-184.
  9. Лукьянова, Е.М. Нефротоксичность антибиотиков у новорожденных / Е. М. Лукьянова // Качественная клин. практика [Электронный ресурс]. – 2002.– Режим доступа: http://www.medi.ru. – Дата доступа: 15.12.2006.
  10. Pharmacokinetic dosing of aminoglycosides: a controlled trial / С. Bartal [et al.] // Am. J. Med. – 2003. – Vol. 114, N. 3. – Р. 194-198.
  11. Prospective evaluation of the effect of an aminoglycoside dosing regimen on rates of observed nephrotoxicity and ototoxicity / M. Rybak [et al.] // Antimicrob. Agents Chemother. – 1999. – Vol. 43, N 7. – Р. 1549-1555.
  12. Variation in gentamicin-induced death among independent cultures of proximal tubule cells / M. A. Sens [et al.] // Ann. Clin. Lab. Sci. – 1993. – Vol. 23, N 5. – P. 362-368.
  13. Single or multiple daily doses of aminoglycosides: a meta-analysis / M. Barza [et al.] // BMJ. – 1996. – Vol. 312, N. 10. – Р. 338-344.
  14. Aminoglycoside Prescribing and Surveillance in Cystic Fibrosis / H. Kelvin [et al.] // Am. J. Respir. Crit. Care Med. – 2003. – Vol. 167. – Р. 819-823.
  15. Inhibitory effects of gentamicin on renal mitochondrial oxidative phosphorylation / C. F. Simmons [et al.] // Ann. Clin. Lab. Sci. – 1980. – Vol. 214. – P. 709-715.
  16. Бушма, К. М. Роль функционального состояния митохондрий почек в предрасположенности кроликов к нефротоксичности гентамицина / К. М. Бушма // Токсикологический вестник. – 2005. – № 6. – С. 25-30.
  17. Бушма, К. М. Роль систем перекисного окисления липидов и антиоксидантной защиты почек в предрасположенности кроликов к нефротоксичности гентамицина / К. М. Бушма // Эксперим. и клин. фармакология. – 2006. – Т. 69, № 1. – С. 33-37.
  18. Роль индивидуальных особенностей строения почек в предрасположенности кроликов к нефротоксичности гентамицина / К. М. Бушма [и др.] // Бюллетень эксперим. биологии и медицины. – 2004. – Т. 38, № 11. – С. 544-549.
Contacts | ©Vitebsk State Medical University, 2007